Bovine Colostrum to Prevent Absorption of Gluten
Megadott ok: Disengagement from sponsor, no funding provided since 2022.
A legfontosabb adatok
- Hol
- Boston (Egyesült Államok)A helyszín megnézése
- Fázis
- Korai 1. fázis
Helyszínek itt: Egyesült Államok
- Beth Israel Deaconess Medical CenterBoston, Egyesült ÁllamokNo longer taking part
A vizsgálat adatai
- Ki végzi
- Milky Way Life Sciences LLC
- Azonosító
- NCT05555446
- A regiszteradat frissítve
- 2024. december 4.
- Eredeti leírás
To investigate the use of hyperimmune bovine colostrum to reduce gluten absorption.A teljes eredeti leírásKevesebb
In-vivo Study of the Efficacy of Hyperimmune Bovine Colostrum to Block Absorption of Gliadin Peptides in the Human Intestine: a Novel Potential Intervention for Celiac Disease and Non-celiac Gluten Sensitivity
To investigate the use of hyperimmune bovine colostrum to reduce gluten absorption.
A double-blind, cross-over study will be performed in which persons who are following a strict gluten-free diet will be challenged with oral gluten with or without the bovine colostrum.
Bevonási feltételek: Self-reported strict adherence to a gluten-free diet for at least 3 months. This may be a lifestyle choice, in solidarity with a child or other family/household member with celiac disease, because of non-celiac gluten sensitivity or because of celiac disease; Willing to provide informed consent for all study procedures; Healthy volunteer according to the investigator assessment (history and physical exam).
Kizáró feltételek: Known active gastrointestinal disease; History of severe symptomatic reactions to gluten or milk proteins; History of allergy to beef or meat; History of allergy to apple; Any medication or medical condition which, in the opinion of the investigators, could adversely affect the patient's participation in the trial; Allergy to PPI or other contraindication for PPI use (i.e history of interstitial nephritis attributed to PPI, history of PPI-induced diarrhea); Definite or probable gluten exposure during the 72 hours preceding each study intervention visit; Use of an oral digestive enzyme supplement during the 72 hours preceding each study intervention (challenge) visit; Severe lactose intolerance; Pregnant women (according to pregnancy test).